iShares US Pharmaceuticals ETF
IHE
IHE
96 hedge funds and large institutions have $96.6M invested in iShares US Pharmaceuticals ETF in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 30 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
23% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 30
35% less capital invested
Capital invested by funds: $148M → $96.6M (-$51.1M)
Holders
96
Holding in Top 10
1
Calls
$3.01M
Puts
$816K
Top Buyers
| 1 | +$7.84M | |
| 2 | +$5.41M | |
| 3 | +$1.49M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$1.15M |
| 5 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
+$1.04M |
Top Sellers
| 1 | -$31.4M | |
| 2 | -$4.11M | |
| 3 | -$2.45M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.23M |
| 5 |
Jane Street
New York
|
-$1.39M |